Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection

Name: Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection
Published: 2015
License: Public Domain

Janssen Research & Development, LLC · 2015

ClinicalTrials.gov · Datasets · License: Public Domain · 2015

Open Source ↗

cirrhosis hepatitiscvirus

hepatitis c virus, hepatitis c virus genotype 1, chronic hepatitis c virus genotype 1 infection, liver fibrosis, cirrhosis, simeprevir, daclatasvir, sofosbuvir, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection

Related documents